πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,641 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9533990

Inhibitors of secretion of hepatitis B virus antigens

ARBUTUS BIOPHARMA CORPORATION Β· Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9528094

Attenuated African swine fever virus vaccine based in the deletion of MGF genes

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9526777

Methods for the induction of ebola virus-specific immune responses comprising administerin

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9518096

Virus-like particles comprising composite capsid amino acid sequences for enhanced cross r

Takeda Vaccines, Inc. Β· Granted Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9518056

Inhibitors of influenza viruses replication

Vertex Pharmaceuticals Incorporated Β· Granted Tue Dec 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9504701

Methods for treating viral infections using hydrogen sulfide donors

The Board of Regents of the University of Texas System Β· Granted Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9504762

Adeno-associated virus factor VIII vectors

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9499608

Bispecific monoclonal antibody therapeutics against West Nile virus with improved CNS pene

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9499595

Development of influenza A antivirals

The Board of Regents of the University of Texas System Β· Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9499588

Flaviviruses expressing the prM, E, and NS1 proteins of other flaviviruses and uses thereo

The Board of Regents of the University of Texas System Β· Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9499821

Preventing or treating viral infection using an inhibitor of the LSD1 protein, a MAO inhib

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9498529

Methods for treating or preventing influenza virus infection by administering a serine pro

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9498526

Human rotavirus vaccine strains and diagnostics

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9492415

Methods of treating Parkinson's disease using viral vectors

The Regents of the University of California Β· Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9486539

Nipah virus envelope pseudotyped lentiviruses and methods of their use

The Regents of the University of California Β· Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9487563

Virus-like particles and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9486518

Membrane proximal region of HIV GP41 anchored to the lipid layer of a virus-like particle

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9475832

Phosphonates with reduced toxicity for treatment of viral infections

The Regents of the University of California Β· Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9474797

African swine fever virus georgia strain adapted to efficiently grow in the vero cell line

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9474796

Crimean-Congo hemorrhagic fever virus vaccine

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9474793

Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and hepatitis B

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9463234

Attenuated african swine fever virus strain induces protection against challenge with homo

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9463233

Avirulent, immunogenic flavivirus chimeras

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9458517

Adeno-associated virus virions with variant capsid and methods of use thereof

The Regents of the University of California Β· Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted